Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Shared Hospital Services (AMS) Gains from Sales and Divestitures (2020 - 2024)

American Shared Hospital Services (AMS) has 5 years of Gains from Sales and Divestitures data on record, last reported at $120000.0 in Q4 2024.

  • For Q4 2024, Gains from Sales and Divestitures rose 33.33% year-over-year to $120000.0; the TTM value through Dec 2024 reached $120000.0, up 33.33%, while the annual FY2024 figure was $120000.0, 33.33% up from the prior year.
  • Gains from Sales and Divestitures reached $120000.0 in Q4 2024 per AMS's latest filing, up from $90000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $168000.0 in Q4 2021 and bottomed at $90000.0 in Q4 2020.
  • Average Gains from Sales and Divestitures over 5 years is $120000.0, with a median of $120000.0 recorded in 2024.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 86.67% in 2021, then tumbled 31.82% in 2023.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $90000.0 in 2020, then skyrocketed by 86.67% to $168000.0 in 2021, then dropped by 21.43% to $132000.0 in 2022, then crashed by 31.82% to $90000.0 in 2023, then surged by 33.33% to $120000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $120000.0 in Q4 2024, $90000.0 in Q4 2023, and $132000.0 in Q4 2022.